SLAMF1 and X-linked lymphoproliferative disease: It has been reported that there are three putative acting mechanisms that could cause XLP due to mutation in SH2D1A, including reduced gross expression, reduced ability binding to SLAM family receptors and inability to activate signal transduction downstream of the SLAM receptor–SAP complex efficiently [18].